METTL3 and metabolic dysfunction-associated steatotic liver disease: NAFLD is a complex metabolic disease and many pathological changes happened in liver tissue (94).The RNA m6A methylation regulator FTO, METTL3, and the recognition protein family YTHDF affect the progression of NAFLD to hepatocellular carcinoma (HCC) by the means of disorder lipid metabolism, oxidative stress (87), and autophagy (80), making it an important potential treatment target.